The research, led by pharmacist-researcher Aili Langford of the University of Sydney and Monash University’s Centre for Medicine Use and Safety, together with colleagues including deprescribing specialists Barbara Farrell of the Bruyère Research Institute in Ottawa, Wade Thompson of the University of British Columbia, and Emily Reeve of Monash University, involved in-depth interviews with 24 Australian healthcare professionals. The sample comprised ten medical practitioners—specialists spanning cardiology, clinical pharmacology, emergency medicine, general practice, geriatrics, nephrology, and psychiatry—alongside nine pharmacists and five nursing professionals, recruited across five Australian states and territories through professional organizations, social media, and the Australian Deprescribing Network. Between March and October 2024, participants completed semi-structured interviews lasting 33 to 56 minutes, in which they dissected real deprescribing recommendations drawn from published guidelines, ranked deliberately varied versions of the same recommendation, and explained what would make them follow such advice at the bedside. The team then analyzed the transcripts with thematic framework analysis, deductively mapping the data onto the Guideline Language and Format Instrument, or GLAFI—a validated tool that specifies how the wording, structure, and layout of guideline recommendations determine whether clinicians adopt them or abandon them—while remaining alert to themes the instrument could not capture.

The stakes are anything but academic. Deprescribing—the clinician-supervised process of tapering or stopping medications that are inappropriate or no longer necessary—remains uncommon, while the global prevalence of potentially inappropriate medication use continues to climb. Single-disease guidelines, which dominate clinical practice, routinely fail to account for older adults living with multiple conditions, generating stacks of disease-specific recommendations that can cumulatively promote polypharmacy, drug interactions, and medication-related harm. Class-specific deprescribing guidelines do exist for benzodiazepines, proton pump inhibitors, antipsychotics, and antihyperglycemic agents, among others, but their advice has never been routinely woven into mainstream treatment guidelines. A recent scoping review by the same research group found that only two percent of evidence-based deprescribing recommendations were supported by high-certainty evidence—a stark measure of the evidentiary hole that guideline developers are being asked to write their way out of.

The first and most striking finding was a double standard. Participants consistently described deprescribing as a distinct, more complex, and higher-risk clinical activity than initiating a drug, and consequently demanded far more from any recommendation telling them to do it. They wanted the full decision logic spelled out—who is suitable for deprescribing, who is responsible, which medications, when, and why—but above all, how: explicit tapering regimens, monitoring parameters, co-interventions, and strategies for engaging patients in the conversation. “With deprescribing, it’s much more common than in prescribing to have to work out complex regimens…a little bit of handholding would definitely make someone more comfortable,” one physician told the researchers. GLAFI’s content checklist asks developers to state the action to be performed, by whom, for whom, and under what conditions, yet stays silent on these operational mechanics—the precise gap participants kept flagging. The authors argue the instrument itself will need extending for de-implementation, the deliberate withdrawal of established practices, which poses challenges that implementation frameworks built for rolling out new interventions were never designed to handle.

Stopping a medication also collides with deeply ingrained clinical psychology. Participants summarized the prevailing mentality bluntly: “adding things is doing good, taking things away is doing bad.” Because deprescribing is rarely incentivized in practice settings while prescribing is reinforced by clear guidance, workflow defaults, and entrenched habit, clinicians default to continuation—a pattern the researchers frame as clinical inertia. To counter it, participants favored direct, active-voice language of the form “we recommend A for B” over hedged phrasing like “consider this,” paired with explicit statements of the relative advantage of stopping, whether the benefit of deprescribing or the harm of continued use. Perceived legal exposure sharpened the reluctance: “It takes balls to deprescribe something that someone’s been on for a long time,” one physician admitted. And because deprescribing typically aims to avert future harm rather than deliver immediate benefit, the persuasive framing that props up prescribing recommendations is intrinsically harder to construct for the reverse maneuver.

Evidence, or the perceived absence of it, compounded the hesitancy. Many participants assumed deprescribing recommendations rest on expert consensus rather than robust trials—”it would be some well-intentioned group of clinicians coming up with what seems reasonable,” in one physician’s words—and several said weak, low-certainty recommendations were so off-putting that they would rather the evidence ratings be omitted entirely, even though that would violate current best practices in guideline development. The researchers argue this reflects a misunderstanding of what evidence ratings mean rather than a genuine design flaw, and calls instead for plain-language interpretation of GRADE-style ratings and targeted clinician education. Participants also exposed a striking double standard: prescribing recommendations built on trials conducted in younger, healthier populations are applied to older, more complex patients without question, while deprescribing advice lacking direct evidence is met with suspicion. Some argued that the absence of evidence for a drug’s ongoing benefit should itself justify stopping it, and that guidelines should distinguish “evidence of no benefit” from “no current evidence of benefit” so clinicians can judge for themselves—while still anchoring decisions in patient goals and preferences rather than rigid evidence thresholds.

The second theme captured a tension every guideline writer will recognize: clinicians want recommendations that are simultaneously succinct and complete. Ambiguous verbs were a particular worry. Terms such as “de-escalate,” “taper,” and “withdraw” leave it unclear whether dose reduction, abrupt cessation, or both are intended—a gap that can translate directly into harm when a drug requiring gradual weaning is stopped cold. “Taper slowly means nothing to anybody. Slowly for one person is a day and another person is a month…I think it’s quite easy for something like this to be misinterpreted or misapplied,” one pharmacist explained. Participants called for standardized, precise terminology—for example, “discontinue”—supported by glossary definitions, and they generally praised bullet points, color coding to signal evidence strength, and clinical algorithms that strip cognitive load from dense text and speed up decisions in time-poor environments.

Yet the same participants, when shown fully detailed step-by-step recommendations, judged them long, cumbersome, and overwhelming—text that nobody would actually read in a busy clinic. Recommendations offering multiple tapering regimens and co-intervention options triggered decision fatigue, delaying or deferring choices altogether. Intriguingly, some participants defended a degree of deliberate ambiguity, arguing that overly directive instructions risk a one-size-fits-all approach that tramples individual patient goals, while others complained that open-ended guidance left them feeling unsafe making the call. “The guidelines are meant to be guidelines, right? They’re meant to be giving you a direction. When it’s kind of open, I don’t feel good about making that call,” one physician said, while another bristled at the prospect of a “cookbook of medicine.” The authors suggest the resolution lies in flexibility of format rather than ambiguity of language: layered resources combining comprehensive technical documents, concise clinical tools, and plain-language summaries, plus multiple tailored options where the optimal strategy is genuinely uncertain.

Placement proved equally consequential. Some clinicians wanted deprescribing advice co-located with prescribing recommendations, so that the question of eventual withdrawal surfaces at the very moment of initiation, shifting deprescribing from a reactive response to adverse events—a fall, a hospitalization—toward proactive planning. “You might be prescribing it with no thought or intention of deprescribing it. But if you see that at the bottom of the article…you’re like, oh, hang on…I need to plan to wean this,” one physician reflected. Others preferred a standalone deprescribing section, reasoning that clinicians rarely open a hypercholesterolemia guideline to ponder statin withdrawal and that a dedicated section can hold broader principles and patient-conversation strategies beyond medication-specific advice. There was consensus, however, that paper alone is not enough: deprescribing advice must be embedded in national medicine handbooks, formularies, and prescribing and dispensing software, delivered as context-sensitive, patient-data-driven prompts engineered to avoid the alert fatigue that buries clinicians under notifications. Participants even envisioned artificial intelligence systems cross-referencing prescribing behavior against guidelines in real time, reducing reliance on external documents altogether.

Synthesizing the themes, the team distilled seven implementability design principles for deprescribing recommendations: specify the full decision logic—who, what, when, why, and how; use active, directive language with harmonized verbs; counteract clinical inertia with positive framing that states the relative advantage of stopping; standardize terminology and define it in a glossary; communicate the strength and certainty of evidence clearly, with plain-language interpretation; visualize information through bullet points, flowcharts, and algorithms; and place recommendations where clinicians will actually act on them, whether alongside prescribing guidance, in a dedicated section, or within digital workflows. The findings have already informed an international clinician survey designed to test preferred content, format, and terminology across a broader sample. The authors acknowledge the study’s limits—a qualitative design, an Australian volunteer sample, and analysis led by researchers with pharmacy backgrounds—while arguing the principles target universal features of clinical cognition, from cognitive load to the appetite for clear, directive guidance. If they hold up, guideline developers finally have a concrete recipe for writing the half of prescribing that has gone unwritten—a step that could shrink the burden of medications patients no longer need, before another 92-year-old like the nurse participant’s “Dot,” who fell while taking “a truckload of anti-hypertensives,” pays the price for medicine’s silence.

The burgeoning field of neonatal habilitation is gaining traction as a means to support the developmental needs of infants in NICUs. This study highlights how therapists perceive the barriers rooted in practice, as well as the contextual solutions that can be explored to mitigate these hurdles. The therapeutic process in NICUs encompasses not just treating the immediate medical conditions of premature infants but also fostering their sensory, cognitive, and physical development during a critical period of growth. The therapist’s role is foundational, bridging medical care with developmental support.

Interestingly, the therapists in this study identified multiple layers of barriers that interfere with the delivery of effective neonatal habilitation. These challenges are not merely physical, but they also stem from systemic issues within the healthcare framework. Factors such as inadequate staffing, limited resources, and insufficient training can diminish the quality of care provided to vulnerable infants. Additionally, the integration of therapeutic practices into medical protocols often lacks the emphasis it deserves, highlighting an urgent need for advocacy and policy reform that voices the importance of habilitative care in NICUs.

Further complicating the delivery of care, cultural perceptions and societal attitudes towards disability and developmental challenges in infants play a significant role. Therapists noted that there exists a prevalent stigma regarding developmental delays, which can impact how families engage with the NICU environment. Without awareness and education on the importance of habilitation, families may struggle to prioritize the therapeutic activities deemed essential for their infants’ development. This interaction between therapist and family is critical, and initiatives aimed at educating families could significantly enhance engagement in therapy sessions.

Among the solutions proposed by therapists were a series of systematic changes that could vastly improve neonatal habilitation practices in the NICU context. Training programs tailored for healthcare professionals that focus on the integration of habilitative strategies into medical care have been touted as essential. These programs could equip therapists and nurses with the tools needed to implement evidence-based practices that promote development alongside traditional medical interventions. Comprehensive development frameworks must be adopted, encouraging multidisciplinary collaboration that includes not only therapists but also medical staff, nutritionists, and psychosocial support teams.

Moreover, therapists emphasized the importance of community-based rehabilitation and follow-up services that can extend beyond the NICU setting. Infants who graduate from NICUs should have access to continued support and therapeutic interventions as they transition into home life. This transition is a pivotal moment that can significantly affect the trajectory of their development. Establishing a network of support that includes aftercare services would help families navigate the often-challenging road of continued habilitation.

In addition, therapists highlighted the necessity for greater research investment in neonatal habilitation, advocating for robust funding that prioritizes this crucial area of infant care. This would not only facilitate further studies but also ensure that the results of such investigations translate into real-world interventions. As knowledge in this field expands, developing innovative approaches to neonatal habilitation could significantly enhance quality of care and improve long-term outcomes for infants.

The findings of this qualitative exploration provide a clear call to action for stakeholders involved in neonatal health. Policymakers must recognize the implications of these barriers and actively work to create an enabling environment for effective neonatal habilitation. As healthcare systems increasingly recognize the value of holistic care, the narratives shared by therapists should inform policy and inspire systemic change that prioritizes the developmental needs of infants in NICUs.

In conclusion, the perspectives of therapists on barriers and solutions in neonatal habilitation underscore the importance of integrating developmental care into the NICU framework. The exchange of ideas and experiences can catalyze change at both the policy level and within individual institutions. As this study reveals, addressing the challenges faced by therapists is key to improving care and ensuring a positive developmental trajectory for vulnerable infants. With robust support and systematic reforms, the future of neonatal habilitation in India can be not only bright but transformative, offering hope to families navigating the complexity of neonatal care.

This study invites readers to reconsider the narratives around neonatal care and highlights the crucial role that therapists play in shaping those narratives. As research in this sphere continues to grow, it is imperative to keep the conversation going, advocating for awareness, support, and actionable strategies that will ultimately uplift neonatal care practices across the globe.

Subject of Research: Barriers and solutions in neonatal habilitation across Indian Neonatal Intensive Care Units.

Article Title: Practice-informed barriers and contextual solutions in neonatal habilitation across Indian Neonatal Intensive Care Units: A qualitative exploration of therapists’ perspectives.

Article References:

J. R., A., Kanniappan, V. Practice-informed barriers and contextual solutions in neonatal habilitation across Indian Neonatal Intensive Care Units: A qualitative exploration of therapists’ perspectives. BMC Pediatr (2026). https://doi.org/10.1186/s12887-026-06533-y

Image Credits: AI Generated

DOI:

Keywords: Neonatal care, neonatal habilitation, NICU, therapists, qualitative research, barriers, solutions, developmental care.

Frail older adults often have multiple comorbidities, polypharmacy, and varying degrees of functional impairment. These factors contribute to the complexity of prescribing anticoagulants safely and effectively. The findings from the DOAC-FRAIL questionnaire survey provide vital insights that healthcare professionals can leverage to improve clinical practices. The voices of these professionals highlight a myriad of factors influencing their decision-making processes, extending beyond simple clinical guidelines to encompass patient-centered considerations.

One of the striking elements revealed by the study is the recognition of individual patient characteristics that must be taken into account when prescribing DOACs. Providers express a growing awareness of the variability in treatment tolerability and efficacy across different subsets of older adults. Attentiveness to renal function, history of falls, and cognitive status emerges as pivotal factors that can sway prescribing decisions. This acknowledgment emphasizes that a one-size-fits-all approach is insufficient; rather, prescribers must tailor their strategies to the unique needs of each patient.

The survey’s results demonstrate an overarching concern regarding the lack of comprehensive guidelines specifically addressing frail elders. Despite a wealth of research focusing on the effectiveness of DOACs in the general population, the nuanced specter of frailty presents a challenge for prescribers. The authors suggest that more robust clinical guidelines are essential to fill this gap, allowing healthcare professionals to navigate the complexities with greater confidence.

Another significant takeaway from the study is the ongoing education required to ensure healthcare professionals are adequately trained in the subtleties of prescribing for frail older patients. Many prescribers report feeling uncertain about the appropriate use of DOACs, especially in the context of varying clinical scenarios that may arise in this diverse population. This finding accentuates the importance of continuous medical education and collaborative learning environments that engage healthcare providers in discussions about best practices.

The DOAC-FRAIL questionnaire not only captures the perspectives of prescribers but also emphasizes the importance of interprofessional collaboration. The study stresses the value of involving pharmacists and geriatric specialists in the prescribing process to enhance safety and efficacy. A multi-disciplinary approach can provide a holistic view of the patient’s health, ensuring that all aspects of their well-being are taken into account when considering anticoagulation therapy.

Moreover, the hesitance to prescribe DOACs for frail patients may also stem from concerns about the potential for adverse events. The integration of shared decision-making into clinical practice highlights how vital it is for healthcare providers to engage patients in discussions surrounding their treatment options. This dialogue can alleviate concerns and foster a collaborative environment, where patients feel empowered to voice their preferences and fears regarding anticoagulation therapy.

As public and healthcare systems increasingly prioritize patient safety, the implications of prescribing DOACs to frail older adults become even more critical. The potential for major complications, such as bleeding risks, must be carefully weighed against the benefits of anticoagulation, particularly when treating patients with a history of stroke or atrial fibrillation. The survey findings serve as a reminder that ongoing risk assessments are essential in monitoring patients throughout their treatment journey.

In light of increasing frailty among the aging population, tailoring anticoagulation strategies for older adults is no longer a matter of choice but of necessity. The survey results emphasize the immediate need for research to further understand the pharmacokinetics and pharmacodynamics of DOACs in this group. By leveraging existing data while encouraging innovative studies, researchers can help optimize treatment protocols.

The exploration of healthcare professionals’ perspectives through the DOAC-FRAIL questionnaire not only highlights existing gaps in knowledge but also calls for interdisciplinary discussions to shape future studies. By harnessing insights from multiple stakeholders, including physicians, nurses, and allied health professionals, a more comprehensive understanding of frailty and anticoagulation can emerge—ripe for implementation in clinical environments.

With the growing burden of frailty in older adults, healthcare systems worldwide face the pressing challenge of adapting their practices. This adaptability requires the integration of a patient-centered approach, aiming for not just clinical efficacy but also improved quality of life for patients. The findings from the DOAC-FRAIL questionnaire can therefore serve as a catalyst for enhancing standards of care and fostering innovative solutions in anticoagulation therapy.

As aging demographics continue to shift, the dialogue surrounding frail older patients and their treatment remains critical. This study reinforces the value of capturing the perspectives of healthcare professionals in order to develop more informed clinical guidelines and practices. Achieving excellence in patient care for frail older patients would benefit significantly from an ongoing commitment to research and education aimed at refining anticoagulation strategies.

In conclusion, the urgent need to address frailty in elderly populations calls for a profound understanding of the complexities surrounding DOAC prescriptions. The insights shared through the DOAC-FRAIL questionnaire provide a foundation for building a safer, more effective framework for delivering anticoagulation therapy to frail older patients, ultimately improving their health outcomes and overall quality of life. Continued research, education, and collaborative practice are essential in paving the way forward in geriatric medicine.

Subject of Research: Healthcare professionals’ perspectives on prescribing DOACs to frail older patients.

Article Title: Healthcare professionals’ perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire.

Article References:

de Jong, M., Brys, A.D., Braeken, D. et al. Healthcare professionals’ perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire.
BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-06972-3

Image Credits: AI Generated

DOI: 10.1186/s12877-026-06972-3

Keywords: DOACs, frail elderly, anticoagulation therapy, healthcare professionals, patient-centered care, geriatric medicine, clinical practice, shared decision-making.

At the heart of this study lies a critical examination of how language shapes experiences and perceptions in the realm of health care. The researchers set out to investigate the prevailing attitudes toward gender-inclusive terminology among health care providers in Canada, a country often regarded as a leader in progressive health policies. Through their methodical inquiry, they aimed to uncover not only the challenges practitioners face in implementing such language but also the benefits that inclusive language can bring to patient experiences and outcomes.

The modified Delphi survey employed by the researchers consisted of multiple rounds of questioning, where experts in the field were asked to provide their input on various aspects of gender-inclusive language. This iterative process allowed for a comprehensive gathering of ideas, leading to a nuanced understanding of the role language plays in shaping health care interactions. By incorporating a range of perspectives from clinical practitioners, policymakers, and community advocates, the researchers were able to paint a clearer picture of the current landscape surrounding gender-inclusive practices.

One of the key findings from this study was the recognition that language is not merely a tool for communication but a powerful influence that can either empower or alienate patients. Many health care professionals acknowledged that using gender-inclusive language is vital for fostering an environment of trust and respect. Patients who feel acknowledged and validated in their identities are more likely to engage with health care systems, which can lead to improved health outcomes. The research underscores the need for educational initiatives aimed at training health care providers in the use of inclusive language, ensuring that they are equipped to meet the diverse needs of their patients.

Furthermore, the study highlighted the ongoing challenges faced by practitioners in adopting gender-inclusive language within clinical settings. While many professionals expressed a desire to be inclusive, they often encountered barriers such as institutional norms, lack of awareness, and the fear of making mistakes. This hesitance can create a reluctance to engage in conversations about gender identity, which ultimately undermines the goal of providing equitable care. The researchers advocate for ongoing professional development that emphasizes the importance of gender inclusivity and offers practical strategies for overcoming these challenges.

Another significant finding from the survey was the need for clear guidelines and standardized language practices in health care settings. Many respondents indicated that the absence of widely accepted definitions and terminology surrounding gender inclusivity often leads to confusion and inconsistency in practice. Developing comprehensive resources that outline recommended language use could help bridge these gaps and promote a more uniform approach to gender inclusivity in health care.

The implications of this research extend beyond the Canadian context, resonating with global conversations about gender and health care. As societies grapple with the complexities of gender identity and expression, the need for inclusive policies and practices becomes increasingly apparent. The findings of this study serve as a call to action for health care systems worldwide to prioritize gender inclusivity and to recognize the profound impact language can have on patient care.

In conclusion, the research conducted by Goldberg, Thorne, and Khan represents a crucial step forward in understanding the importance of gender-inclusive language in health care. The insights gleaned from the modified Delphi survey illuminate not just the challenges faced by practitioners but also the tremendous potential for positive change. By embracing inclusive language and fostering educational initiatives, health care professionals can create more welcoming environments that ultimately lead to healthier outcomes for all patients. The study’s findings reinforce the notion that language is a living entity, continuously evolving to reflect the diverse identities of those it serves.

The journey toward embracing gender-inclusive language in health care is ongoing, but this study provides a framework for achieving meaningful progress. By engaging in open dialogue, advocating for inclusive policies, and committing to continued professional development, health care systems can pave the way for a future where every individual feels seen, heard, and valued within the health care continuum.

As we look forward, it is essential for all stakeholders, including educators, policymakers, and health care providers, to work collaboratively in fostering a culture of inclusivity. The landscape of health care is constantly evolving, and it is crucial that language evolves alongside it to truly reflect and honor the identities of all individuals.

Ultimately, the study by Goldberg and colleagues emphasizes that the journey toward gender inclusiveness in health care is not just a matter of policy; it is a fundamental human right. Creating a health care system that recognizes and affirms diverse identities is vital to ensuring that everyone has access to compassionate and effective care. The insights gathered from this research will undoubtedly serve as a catalyst for ongoing dialogue and action within the health care community, propelling us toward a more inclusive future.

Subject of Research: Perspectives on gender-inclusive language in Canadian sexual and reproductive health care.

Article Title: Perspectives on gender-inclusive language in Canadian sexual and reproductive health care: findings from a modified Delphi survey.

Article References:

Goldberg, J.M., Thorne, O.G., Khan, M. et al. Perspectives on gender-inclusive language in Canadian sexual and reproductive health care: findings from a modified Delphi survey.
BMC Health Serv Res (2026). https://doi.org/10.1186/s12913-025-13776-5

Image Credits: AI Generated

DOI:

Keywords: Gender-inclusive language, health care, sexual and reproductive health, Canada, Delphi survey, patient care, professional development, inclusivity.

The study provides a comprehensive analysis of how healthcare workers perceive the major barriers and facilitators that impact the management of individuals with dementia. Through interviews and discussions, the researchers engaged directly with healthcare professionals to gather insights into their experiences and opinions. The findings reveal a multifaceted context where various factors, such as communication, staff training, and institutional policies, intersect to affect the quality of care for these vulnerable patients.

Central to the study’s findings is the recognition of the importance of effective communication both within healthcare teams and with the families of patients. Healthcare professionals expressed concerns about the difficulties in relaying critical information regarding patient behaviors and needs. Such miscommunication can lead to misunderstandings and, ultimately, delays in providing appropriate interventions or support. This underscores the need for improved communication strategies to ensure all parties are adequately informed about patient care requirements, particularly during transitions between different levels of care.

Additionally, the research highlighted the pivotal role of staff training as a key factor in managing challenging behaviors associated with dementia. Many healthcare professionals noted that a lack of specialized training in geriatric psychiatry limits their ability to effectively handle complex behavioral issues. This gap in knowledge can result in reliance on medication as a primary management strategy rather than implementing behavioral interventions that could yield more positive outcomes for patients. Consequently, the authors advocate for a systemic approach to training that empowers healthcare teams with the necessary tools and knowledge to better support this patient population.

The study also explored the influence of institutional policies and practices on re-referral and re-admission. Participants identified significant inconsistencies in how policies were applied across different facilities, often leading to confusion and frustration among staff. Variations in procedures can impact decision-making processes when it comes to referring patients back to psychiatric services or deciding whether to readmit individuals who may have previously been discharged. Harmonizing practices across facilities may enhance continuity of care and improve patient outcomes, the authors suggest.

Moreover, the perspectives shared by healthcare professionals illuminated the emotional challenges they face while caring for patients with dementia and challenging behaviors. Many expressed feelings of helplessness when faced with situations where they felt they could not provide the necessary support or resources for their patients. The psychological toll of witnessing the decline in such patients can lead to burnout among caregivers, emphasizing the need for appropriate mental health support systems for healthcare providers themselves.

Equally important is the involvement of family members in the care process, as they play an irreplaceable role in the lives of dementia patients. Participants in the study articulated the necessity of engaging family members in discussions around care plans and treatment options. A collaborative approach can not only help in delivering more personalized care but can also mitigate the family’s feelings of isolation and distress, fostering a more supportive environment for all involved. Empowering families with knowledge about dementia and behavioral challenges can further enable them to play a proactive role in their loved one’s care.

Alongside these insights, the participants shed light on systemic barriers such as funding issues and a lack of resources that directly affect the quality of care. Limited access to specialized services and support can hinder timely interventions for patients in need, ultimately exacerbating their condition and leading to higher rates of re-referrals and readmissions. This calls into question the adequacy of healthcare funding in geriatric psychiatry and the need for a reevaluation of resource allocation to ensure that those with dementia receive the care they deserve.

In summary, the qualitative study conducted by Rached and Ullmer offers a critical examination of the contextual factors influencing the management of dementia patients in nursing homes. The perspectives of healthcare professionals paint a vivid picture of the challenges and complexities involved in providing optimal care. From communication breakdowns and training deficiencies to the importance of family involvement and systemic barriers, the findings present a holistic view of the landscape in geriatric psychiatry.

As the population ages and the incidence of dementia increases, there is an urgent need for innovations in training, policy, and resource allocation. The implications of this study extend beyond German nursing homes, as the themes identified resonate within many healthcare systems globally. Addressing these challenges will require concerted efforts from policymakers, healthcare administrators, and educators to ensure that the care of the elderly is not only a priority but also executed with compassion, competence, and respect.

In conclusion, this study is a call to action for all stakeholders in the healthcare sector to adopt a more integrated approach to geriatric care. Recognizing and addressing the diverse factors that affect the re-referral and re-admission of dementia patients is crucial for sustainable and effective long-term care solutions. As we move forward, the insights drawn from Rached and Ullmer’s research will serve as a valuable resource for fostering improvements in geriatric psychiatry practice, ultimately aiming to enhance the quality of life for both patients and healthcare providers alike.

Subject of Research: Factors influencing re-referral and re-admission to geriatric psychiatry for dementia patients in nursing homes.

Article Title: Healthcare professionals’ perspectives on contextual factors related to (re)referral and (re)admission to geriatric psychiatry of people with dementia and behaviour that challenges living in nursing homes in Germany: a qualitative study.

Article References:

Henni Rached, I., Ullmer, VF. Healthcare professionals’ perspectives on contextual factors related to (re)referral and (re)admission to geriatric psychiatry of people with dementia and behaviour that challenges living in nursing homes in Germany: a qualitative study.
BMC Nurs 24, 1488 (2025). https://doi.org/10.1186/s12912-025-04117-2

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12912-025-04117-2

Keywords: Dementia, geriatric psychiatry, nursing homes, healthcare professionals, re-referral, re-admission, challenging behavior, communication, staff training, family involvement, systemic barriers.

Geriatric care uniquely intersects with palliative care due to the complex needs of older patients who often suffer from multiple chronic illnesses. Ensuring that these patients receive compassionate and effective care requires a multidisciplinary approach. The findings from the study reveal that healthcare professionals recognize the significance of the Swedish palliative care guide as a crucial tool for enhancing the quality of life of elderly patients. Their insights were obtained through both small-group discussions and individual interviews, allowing for a deep exploration of their attitudes and experiences.

The healthcare professionals involved in the study expressed varying levels of familiarity with the palliative care guide, illustrating a critical gap in knowledge that can influence the quality of care provided to patients. Some reported feeling confident in their abilities to apply the guide, while others indicated that further training and resources would enhance their understanding. Notably, this variability in knowledge underscores the necessity for ongoing education and support for healthcare workers in geriatric settings.

Moreover, the study highlighted the emotional and ethical dimensions that influence healthcare professionals’ willingness to implement the palliative care guide in their practice. Many participants reflected on the importance of compassionate communication and shared decision-making with patients and families. The need for a framework that fosters these interactions was emphasized, as it can significantly impact patients’ experiences and their overall trajectory of care.

Additionally, the research revealed institutional barriers that healthcare professionals face when trying to implement the guide. These obstacles can range from administrative challenges to lack of resources, which ultimately hinder the integration of palliative care practices in geriatrics. Professionals voiced concerns over insufficient staffing and inadequate support, elucidating the systemic issues that can impede effective patient-centered care.

Interestingly, the study’s findings also suggest that collaboration among healthcare teams is a vital factor in successfully implementing the palliative care guide. Participants cited the benefits of interdisciplinary approaches where different healthcare disciplines can share their expertise and support one another. Such collaboration not only encourages a comprehensive understanding of palliative needs but also cultivates an environment where best practices can emerge.

Additionally, the cultural context surrounding palliative care was a significant point of discussion among the professionals. Variations in cultural attitudes towards end-of-life care can influence both patient expectations and healthcare provider practices. The study indicates that healthcare professionals must be aware of these cultural dynamics in order to provide care that is not only appropriate but also resonates with the values and beliefs of their patients.

The study also identified the role of policy in shaping the landscape of palliative care in geriatrics. Participants acknowledged that policies at the institutional and national levels greatly influence the resources available for support and training. Advocating for policy changes that prioritize palliative care integration into geriatrics could be a catalyst for improving care delivery and enabling healthcare systems to better meet the needs of older adults.

As the medical field continues to evolve, the study illuminates the need for ongoing research that evaluates the effectiveness of palliative care frameworks in clinical practice. By understanding the barriers and facilitators to implementation, future studies can develop targeted interventions that address specific challenges faced by healthcare professionals. This ongoing cycle of research, implementation, and evaluation is essential for cultivating a culture of excellence in geriatric palliative care.

Moreover, by amplifying the voices of healthcare professionals in this process, it becomes possible to create more nuanced and effective guidelines that truly reflect the realities of geriatric care. Continuous feedback loops between providers and researchers can ensure that the tools developed are practical, relevant, and ultimately beneficial for patient outcomes.

In conclusion, Möllerberg et al.’s qualitative study represents a significant contribution to the understanding of palliative care in geriatric settings. The insights garnered from healthcare professionals provide a foundation upon which future training, policies, and research can build. By prioritizing these perspectives, the integration of palliative care into geriatrics can be improved, leading to enhanced patient experiences and outcomes for one of society’s most vulnerable populations.

As healthcare systems worldwide grapple with the challenges of an aging population, the importance of effective palliative care cannot be overstated. At the core of this endeavor is the need to listen to the healthcare professionals who are on the front lines, ensuring that they feel equipped, supported, and empowered to provide the best possible care for elderly patients.

Subject of Research: Perspectives of healthcare professionals on implementing the Swedish palliative care guide in geriatrics.

Article Title: Healthcare professionals’ perspectives on implementing the Swedish palliative care guide in geriatrics – a qualitative study using small-group and individual interviews.

Article References:

Möllerberg, ML., Dalhammar, K., Rasmussen, B.H. et al. Healthcare professionals’ perspectives on implementing the Swedish palliative care guide in geriatrics – a qualitative study using small-group and individual interviews.
BMC Geriatr 25, 839 (2025). https://doi.org/10.1186/s12877-025-06516-1

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12877-025-06516-1

Keywords: Palliative Care, Geriatrics, Healthcare Professionals, Implementation, Qualitative Study.

The study pivots on the need for insight into how AI-driven clinical decision support systems (CDSS) are embraced within ophthalmology specifically. While previous research has largely centered on technological capabilities or physician-centric perspectives, Schaffernak and colleagues delve deeper into the sociocultural contexts that shape the integration of these advanced systems. Given the ongoing digital revolution, their work highlights that the mere introduction of technology is insufficient for successful implementation; rather, the intricate web of interactions among users, settings, and intended outcomes must also be considered to gauge efficacy and acceptance.

Through a series of structured interviews with diverse stakeholders in the ophthalmology field, the research identifies critical influences that encircle AI adoption. One significant finding is the role of established workflows—how the introduction of AI systems influences existing processes and how adaptable clinicians are to these changes. The study reveals that resistance to change is not uncommon, largely due to concerns about technology superseding clinical judgment or potential disruptions to patient interactions, which are essential in ophthalmic evaluations.

Equally important is the study’s attention to the educational dimension of AI integration. Practitioners articulate a desire for robust training programs that equip them with the skills necessary to engage with AI tools effectively. The lack of confidence in navigating these complex systems often serves as a barrier to their employment in practice. Schaffernak et al. emphasize that without clear guidelines and thorough training, even the most sophisticated AI technologies can fall short of their promise to enhance clinical decision-making.

Moreover, the research underscores the necessity for interdisciplinary collaboration among ophthalmologists, data scientists, and policy-makers. Success in implementing AI-driven CDSS demands a concerted effort that extends beyond technological developers to include clinical insight, ethical considerations, and patient welfare. The findings illuminate the necessity of creating a symbiotic relationship between technology and human expertise—one where AI supplements rather than replaces human input.

The implications stretch far beyond individual practitioners; they encompass hospital administrations, regulatory bodies, and educational institutions. In grappling with the rapid pace of innovation, administrators must foster an environment conducive to experimentation and learning. Policies must be formulated to facilitate safe trials and iterations of AI systems so that systems can adapt to real-world applications effectively. The drive towards successful AI integration in ophthalmology can thus encourage a broader reevaluation of how digital tools are implemented across various healthcare sectors.

A pivotal aspect of these discussions involves data privacy and ethical considerations. The integration of AI into clinical practice raises profound concerns about patient data security and how sensitive information is handled. Stakeholders express necessitated reassurances regarding the safeguarding of patient privacy, particularly as AI systems often depend on vast datasets. The study reiterates that transparent communication regarding data use is paramount in gaining public trust and ensuring ethical standards remain robust.

In light of these hurdles, the role of patient perspectives becomes increasingly pertinent. Patients, with their unique insights, can greatly influence the trajectory of AI-enabled tools in healthcare. Engaging them in the conversation not only demystifies the technology but also ensures that the developed systems align with their needs and expectations. Schaffernak and colleagues call for active participation from patients to inform design choices and operational implementation, amplifying the importance of empathy in technological advancements.

As innovations continue to proliferate, the study shines a light on the necessity to evaluate the long-term impacts of AI-enabled systems like CDSS in clinical settings. Continuous assessment is crucial, as it allows for the identification of both deficiencies and successes. Performing retrospective analyses on the outcomes produced by these technologies can foster a learning environment where iterative improvements are part of the integration.

In conclusion, the research by Schaffernak et al. is a timely contribution to ongoing discussions about integrating AI technology within healthcare. Their findings firmly establish that successful adoption of AI-driven clinical decision support systems in ophthalmology—or any field, for that matter—is intrinsically linked to understanding and addressing the complex sociotechnical landscape surrounding these innovations. The dynamism of technology demands that healthcare systems evolve accordingly, prioritizing collaboration, education, and patient safety to ensure that advancements genuinely enhance care delivery. The work underscores a collective responsibility among all stakeholders to champion the integration of technology without losing sight of the human experience at its heart.

As AI continues to push the boundaries of what is possible in healthcare, studies like this provide invaluable frameworks for ensuring that technology serves not just efficiently but equitably and ethically. The journey towards smart, successful integration of AI into ophthalmology underscores urgency and potential—echoing a clarion call for sustained dialogue, innovative collaboration, and a steadfast commitment to patient-centric care.

Subject of Research: Sociotechnical influences on the adoption and use of AI-enabled clinical decision support systems in ophthalmology.

Article Title: Sociotechnical influences on the adoption and use of AI-enabled clinical decision support systems in ophthalmology: a theory-based interview study.

Article References:

Schaffernak, I., Cecil, J., Kleine, AK. et al. Sociotechnical influences on the adoption and use of AI-enabled clinical decision support systems in ophthalmology: a theory-based interview study. BMC Health Serv Res 25, 1398 (2025). https://doi.org/10.1186/s12913-025-13620-w

Image Credits: AI Generated

DOI: 10.1186/s12913-025-13620-w

Keywords: AI, clinical decision support systems, ophthalmology, sociotechnical influences, healthcare innovation.

The study is deeply rooted in the experiences and insights of 28 expert clinicians, who provided their perspectives on the multifaceted harms and benefits associated with long-term opioid medication. Chronic pain, defined as persistent pain lasting three months or longer, has seen a rise in prevalence, particularly in the context of non-cancer diagnoses. The implications of this epidemic are profound, necessitating a nuanced approach to pain management that weighs the potential benefits of opioids against the very real risks of addiction, overdose, and exacerbation of pain conditions.

One of the standout findings from this study is the notable lack of consensus among medical professionals regarding the optimal management strategy for chronic non-cancer pain. More specifically, the analysis reveals that only 36% of the experts advocate for the continuation of opioid therapy, while an equal proportion urges for its cessation. This division speaks to the broader tension within the medical community, where the stakes can involve not only a patient’s quality of life but also their long-term health outcomes.

The study’s authors emphasize the dangerous potential associated with rapid tapering of opioids, including withdrawal symptoms and a potential resurgence of chronic pain, or even the onset of mental health crises. Indeed, more than half of the surveyed experts voiced concerns regarding the dangers of abruptly stopping opioid therapy. This sentiment is integral in shaping protocols for pain management, indicating a cautious and calculated approach may be more beneficial than immediate cessation.

In pursuit of alternatives, some clinicians are advocating for transitioning patients to buprenorphine. This medication is notable for its dual action: it alleviates pain while simultaneously reducing the reinforcing effects associated with opioid dependence. By doing this, clinicians hope to mitigate withdrawal symptoms and cravings, ultimately facilitating a safer and more effective treatment regimen for those grappling with chronic pain.

The study also explored the potential benefits of integrating non-opioid therapies into the treatment spectrum, despite some experts being skeptical about their efficacy based on past experiences with these therapies. Emphasis was placed on the importance of shared decision-making between patients and providers, empowering patients to take an active role in their treatment. However, the lack of consensus on the execution of such measures underlines the necessity of establishing clearer guidelines rooted in evidence-based practices.

While most experts acknowledged the adverse effects of co-occurring conditions such as alcohol use and mental health disorders on patient safety, there was considerable variability in opinions regarding the assessment of opioid use disorder and overdose risk. This oversight may reflect a broader systemic issue in pain management, where many providers may prioritize pain relief over comprehensive assessments of potential addiction and risks.

The moral complexities of opioid prescription practices further complicate the issue of managing chronic pain. Kurt Kroenke, M.D., a co-author of the study, highlights that while the beneficial role of opioids in patient pain relief is well-established, the potential for abuse and adverse outcomes necessitates a careful evaluation of each patient’s specific circumstances. Moreover, taking a patient off opioids could lead to significant consequences, including not just the worsening of chronic pain but also the potential for drug-seeking behavior and increased risk of overdose.

Additionally, it’s important to consider the psychological aspects tied to chronic pain management. Patients may develop a dependency on opioids not just for pain relief but as a coping mechanism for underlying mental health issues. Therefore, when contemplating discontinuation of opioids, a multifaceted treatment approach that addresses both physical and psychological factors may be imperative to uphold patient well-being.

While opioid therapy remains a highly debated subject, Kroenke asserts that patients who still grapple with chronic pain despite being on prescribed opioids should be considered candidates for tapering and alternative therapies. This perspective emphasizes not only patient safety but also encourages movement towards treatment strategies that are less reliant on opioids, thereby reducing the potential for long-term dependence.

As the study draws to a close, it highlights the significant implications of professional liability fears, regulatory changes, and health system initiatives that make it challenging to establish clear guidelines on tapering or continuing opioid prescriptions. In this transitional period, the importance of ethical medical care remains critical, advocating for informed consent and dialogue based on mutual respect between healthcare providers and their patients.

In conclusion, the study underscores a critical gap in clinical practice guidelines regarding the management of patients who face risks from both continuing and discontinuing their long-term opioid therapy. Given the continuing evolution of pain management, there is an urgent need for ongoing discourse and research to ensure that clinicians and patients can navigate the complex terrain of chronic pain treatment effectively.

Subject of Research: Management of long-term opioid therapy in chronic pain patients
Article Title: Management of patients at risk of harms from both continuing and discontinuing their long-term opioid therapy: A qualitative study to inform the gap in clinical practice guidelines
News Publication Date: 25-Jan-2025
Web References: PubMed Study
References: Pain Practice
Image Credits: Not applicable

Keywords: Chronic Pain, Opioids, Pain Management, Buprenorphine, Tapering, Patient Safety, Addiction, Mental Health, Non-opioid Therapies, Shared Decision-Making, Healthcare Guidelines.